DANA FONTENOT: Open Payments
NPI 1174819668 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 14 payments from 10 companies in 2025. Trend: 2023 $890 · 2024 $568 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Novo Nordisk Inc | 2 | $36 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| CeQur Corporation | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Corcept Therapeutics | 1 | $14 |
Products named: FARXIGA, Wegovy, GEMTESA, ZAVZPRET, BREZTRI, GVOKE HYPOPEN, CeQur Simplicity, Kerendia.
Industry payments across LA — which companies pay providers there.
